76. Pituitary gonadotropin secretion hyperthyroidism Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 29 /  Drugs : 44 - (DrugBank : 14) / Drug target genes : 5 - Drug target pathways : 15

Pituitary gonadotropin secretion hyperthyroidism and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
76Pituitary gonadotropin secretion hyperthyroidism
46Malignant rheumatoid arthritis
65Primary immunodeficiency
49Systemic lupus erythematosus
2Amyotrophic lateral sclerosis
13Multiple sclerosis/Neuromyelitis optica
113Muscular dystrophy
299Cystic fibrosis
96Crohn disease
83Addison disease
74Prolactin secreting pituitary adenoma
64Thrombotic thrombocytopenic purpura
285Fanconi anemia
60Aplastic anemia
63Idiopathic thrombocytopenic purpura
3Spinal muscular atrophy
53Sjogren syndrome
86Pulmonary arterial hypertension
191Werner syndrome